HTG EdgeSeq™ Reveal Immunophenotyping Signatures
HTG EdgeSeq™ Reveal Immunophenotyping Signatures
- Categories
- White Papers
- Topics:
- Reveal
- Signatures
HTG EdgeSeq™ Reveal Immunophenotyping Signatures
Bustos, M. A., et al. Integrated Assessment of Circulating Cell-Free MicroRNA signatures in Plasma of Patients With Melanoma Brain Metastasis. Cancers 2020, 12, 1692; doi:10.3390/cancers12061692
Garg, R., et al. Inflammatory and Genetic Signatures for Recurrent Oropharynx Cancer. International Journal of Radiation Oncology. 2020 APR 1:106(5);1173. Abstract 288
Szabo, P. M., et al. Association of an Inflammatory Gene Signature with CD8 Expression by Immunohistochemistry (IHC) in Multiple Tumor Types. Poster session presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; June 1, 2019, Chicago, IL.
Download pdf 606KB
View External Link
Bell, A. et al, Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin. Modern Pathology 2018 Jun 28. doi: 10.1038/s41379-018-0088-5. [Epub ahead of print].
Krolewski, A., et. al., Circulating miRNA profiles associated with hyperglycemia in patients with type 1 diabetes mellitus. Diabetes 2018 Feb; db 171207.
Myers R. H., et al. MicroRNAs in CSF as prodromal biomarkers for
Huntington disease in the PREDICT-HD study. Neurology® 2018;90:e 1-9. doi:10.1212/WNL.0000000000004844.
Harpole D., et al. Creation and Early Validation of Prognostic miRNA Signatures for Squamous Cell Lung Carcinoma by the SPECS Lung Consortium. J Thorac Oncol. 2017 Jan; 12(1): S612-S613.
Finn, R. S. et al. Comprehensive Gene Expression Biomarker Analysis of Cyclin-Dependent Kinases 4/6 and Endocrine Pathways From the PALOMA-2 Study. Poster session presented at: San Antonio Breast Cancer Symposium (SABC); 2017 Dec 5-9; San Antonio, TX.
Knudsen E., et al. Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunological Markers. Clin Cancer Res. 2017 Aug 1;23(15):4429
PMID: 28348045
Sharma P., et al. Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2017 Mar 18(3):312
PMID: 28131785
Page last updated May 22, 2023